A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients.
Tsai HJ, Jiang SS, Hung WC, Borthakur G, Lin SF, Pemmaraju N, Jabbour E, Bomalaski JS, Chen YP, Hsiao HH, Wang MC, Kuo CY, Chang H, Yeh SP, Cortes J, Chen LT, Chen TY.
Tsai HJ, et al. Among authors: hung wc.
Sci Rep. 2017 Sep 12;7(1):11253. doi: 10.1038/s41598-017-10542-4.
Sci Rep. 2017.
PMID: 28900115
Free PMC article.
Clinical Trial.